Global Age-Related Macular Degeneration (AMD) AI Screening System Market Research Report 2026(Status and Outlook)
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
The global Age-Related Macular Degeneration (AMD) AI Screening System market size was estimated at USD 85.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 81.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Age-Related Macular Degeneration (AMD) AI Screening System market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Age-Related Macular Degeneration (AMD) AI Screening System market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Age-Related Macular Degeneration (AMD) AI Screening System market.
Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Market Segmentation (by Type)
Hardware
Software
Market Segmentation (by Application)
Medical Institutions
Great Health Scene
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) AI Screening System Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) AI Screening System Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) AI Screening System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) AI Screening System, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Age-Related Macular Degeneration (AMD) AI Screening System market size was estimated at USD 85.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 81.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Age-Related Macular Degeneration (AMD) AI Screening System market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Age-Related Macular Degeneration (AMD) AI Screening System market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Age-Related Macular Degeneration (AMD) AI Screening System market.
Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Market Segmentation (by Type)
Hardware
Software
Market Segmentation (by Application)
Medical Institutions
Great Health Scene
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) AI Screening System Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) AI Screening System Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) AI Screening System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) AI Screening System, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) AI Screening System
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Company (2020-2025)
3.4 Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Age-Related Macular Degeneration (AMD) AI Screening System Market Competitive Situation and Trends
3.6.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM VALUE CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) AI Screening System Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Porter's Five Forces Analysis
6 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region
8.2 North America
8.2.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Airdoc Technology
9.1.1 Airdoc Technology Basic Information
9.1.2 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.1.4 Airdoc Technology SWOT Analysis
9.1.5 Airdoc Technology Business Overview
9.1.6 Airdoc Technology Recent Developments
9.2 Digital Diagnostics
9.2.1 Digital Diagnostics Basic Information
9.2.2 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.2.4 Digital Diagnostics SWOT Analysis
9.2.5 Digital Diagnostics Business Overview
9.2.6 Digital Diagnostics Recent Developments
9.3 Eyenuk
9.3.1 Eyenuk Basic Information
9.3.2 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.3.4 Eyenuk SWOT Analysis
9.3.5 Eyenuk Business Overview
9.3.6 Eyenuk Recent Developments
9.4 RetinaLyze System
9.4.1 RetinaLyze System Basic Information
9.4.2 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.4.4 RetinaLyze System Business Overview
9.4.5 RetinaLyze System Recent Developments
9.5 Optomed
9.5.1 Optomed Basic Information
9.5.2 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.5.4 Optomed Business Overview
9.5.5 Optomed Recent Developments
9.6 Sibionics Technology
9.6.1 Sibionics Technology Basic Information
9.6.2 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.6.4 Sibionics Technology Business Overview
9.6.5 Sibionics Technology Recent Developments
9.7 Aeye Health
9.7.1 Aeye Health Basic Information
9.7.2 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.7.4 Aeye Health Business Overview
9.7.5 Aeye Health Recent Developments
9.8 VUNO
9.8.1 VUNO Basic Information
9.8.2 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.8.4 VUNO Business Overview
9.8.5 VUNO Recent Developments
9.9 Medimaging Integrated Solution
9.9.1 Medimaging Integrated Solution Basic Information
9.9.2 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.9.4 Medimaging Integrated Solution Business Overview
9.9.5 Medimaging Integrated Solution Recent Developments
9.10 EyRIS (SELENA+)
9.10.1 EyRIS (SELENA+) Basic Information
9.10.2 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.10.4 EyRIS (SELENA+) Business Overview
9.10.5 EyRIS (SELENA+) Recent Developments
9.11 Vistel
9.11.1 Vistel Basic Information
9.11.2 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.11.4 Vistel Business Overview
9.11.5 Vistel Recent Developments
9.12 RETINA-AI Health
9.12.1 RETINA-AI Health Basic Information
9.12.2 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.12.4 RETINA-AI Health Business Overview
9.12.5 RETINA-AI Health Recent Developments
9.13 Acer Medical
9.13.1 Acer Medical Basic Information
9.13.2 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.13.4 Acer Medical Business Overview
9.13.5 Acer Medical Recent Developments
10 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET FORECAST BY REGION
10.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast
10.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country
10.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region
10.2.4 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) AI Screening System by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Type (2026-2035)
11.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2026-2035)
11.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Application (2026-2035)
11.2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) AI Screening System
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Company (2020-2025)
3.4 Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Age-Related Macular Degeneration (AMD) AI Screening System Market Competitive Situation and Trends
3.6.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM VALUE CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) AI Screening System Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Porter's Five Forces Analysis
6 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SEGMENTATION BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region
8.2 North America
8.2.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Airdoc Technology
9.1.1 Airdoc Technology Basic Information
9.1.2 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.1.4 Airdoc Technology SWOT Analysis
9.1.5 Airdoc Technology Business Overview
9.1.6 Airdoc Technology Recent Developments
9.2 Digital Diagnostics
9.2.1 Digital Diagnostics Basic Information
9.2.2 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.2.4 Digital Diagnostics SWOT Analysis
9.2.5 Digital Diagnostics Business Overview
9.2.6 Digital Diagnostics Recent Developments
9.3 Eyenuk
9.3.1 Eyenuk Basic Information
9.3.2 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.3.4 Eyenuk SWOT Analysis
9.3.5 Eyenuk Business Overview
9.3.6 Eyenuk Recent Developments
9.4 RetinaLyze System
9.4.1 RetinaLyze System Basic Information
9.4.2 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.4.4 RetinaLyze System Business Overview
9.4.5 RetinaLyze System Recent Developments
9.5 Optomed
9.5.1 Optomed Basic Information
9.5.2 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.5.4 Optomed Business Overview
9.5.5 Optomed Recent Developments
9.6 Sibionics Technology
9.6.1 Sibionics Technology Basic Information
9.6.2 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.6.4 Sibionics Technology Business Overview
9.6.5 Sibionics Technology Recent Developments
9.7 Aeye Health
9.7.1 Aeye Health Basic Information
9.7.2 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.7.4 Aeye Health Business Overview
9.7.5 Aeye Health Recent Developments
9.8 VUNO
9.8.1 VUNO Basic Information
9.8.2 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.8.4 VUNO Business Overview
9.8.5 VUNO Recent Developments
9.9 Medimaging Integrated Solution
9.9.1 Medimaging Integrated Solution Basic Information
9.9.2 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.9.4 Medimaging Integrated Solution Business Overview
9.9.5 Medimaging Integrated Solution Recent Developments
9.10 EyRIS (SELENA+)
9.10.1 EyRIS (SELENA+) Basic Information
9.10.2 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.10.4 EyRIS (SELENA+) Business Overview
9.10.5 EyRIS (SELENA+) Recent Developments
9.11 Vistel
9.11.1 Vistel Basic Information
9.11.2 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.11.4 Vistel Business Overview
9.11.5 Vistel Recent Developments
9.12 RETINA-AI Health
9.12.1 RETINA-AI Health Basic Information
9.12.2 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.12.4 RETINA-AI Health Business Overview
9.12.5 RETINA-AI Health Recent Developments
9.13 Acer Medical
9.13.1 Acer Medical Basic Information
9.13.2 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
9.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Market Performance
9.13.4 Acer Medical Business Overview
9.13.5 Acer Medical Recent Developments
10 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET FORECAST BY REGION
10.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast
10.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country
10.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region
10.2.4 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) AI Screening System by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Type (2026-2035)
11.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2026-2035)
11.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Application (2026-2035)
11.2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (M USD)
Table 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
Table 5. Age-Related Macular Degeneration (AMD) AI Screening System Market Size Comparison by Region (M USD)
Table 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) by Company (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) AI Screening System as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Age-Related Macular Degeneration (AMD) AI Screening System Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (M USD)
Table 22. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) by Type (2020-2025)
Table 23. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Type (2020-2025)
Table 24. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
Table 25. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
Table 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2020-2025) & (M USD)
Table 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application (2020-2025)
Table 28. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 30. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2020-2025)
Table 31. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 34. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 36. Airdoc Technology Basic Information
Table 37. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 38. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Airdoc Technology SWOT Analysis
Table 40. Airdoc Technology Business Overview
Table 41. Airdoc Technology Recent Developments
Table 42. Digital Diagnostics Basic Information
Table 43. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 44. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Digital Diagnostics SWOT Analysis
Table 46. Digital Diagnostics Business Overview
Table 47. Digital Diagnostics Recent Developments
Table 48. Eyenuk Basic Information
Table 49. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 50. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Eyenuk SWOT Analysis
Table 52. Eyenuk Business Overview
Table 53. Eyenuk Recent Developments
Table 54. RetinaLyze System Basic Information
Table 55. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 56. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 57. RetinaLyze System Business Overview
Table 58. RetinaLyze System Recent Developments
Table 59. Optomed Basic Information
Table 60. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 61. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Optomed Business Overview
Table 63. Optomed Recent Developments
Table 64. Sibionics Technology Basic Information
Table 65. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 66. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Sibionics Technology Business Overview
Table 68. Sibionics Technology Recent Developments
Table 69. Aeye Health Basic Information
Table 70. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 71. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Aeye Health Business Overview
Table 73. Aeye Health Recent Developments
Table 74. VUNO Basic Information
Table 75. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 76. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 77. VUNO Business Overview
Table 78. VUNO Recent Developments
Table 79. Medimaging Integrated Solution Basic Information
Table 80. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 81. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Medimaging Integrated Solution Business Overview
Table 83. Medimaging Integrated Solution Recent Developments
Table 84. EyRIS (SELENA+) Basic Information
Table 85. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 86. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 87. EyRIS (SELENA+) Business Overview
Table 88. EyRIS (SELENA+) Recent Developments
Table 89. Vistel Basic Information
Table 90. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 91. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Vistel Business Overview
Table 93. Vistel Recent Developments
Table 94. RETINA-AI Health Basic Information
Table 95. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 96. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 97. RETINA-AI Health Business Overview
Table 98. RETINA-AI Health Recent Developments
Table 99. Acer Medical Basic Information
Table 100. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 101. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Acer Medical Business Overview
Table 103. Acer Medical Recent Developments
Table 104. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2026-2035) & (M USD)
Table 105. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2026-2035) & (M USD)
Table 111. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (M USD)
Table 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
Table 5. Age-Related Macular Degeneration (AMD) AI Screening System Market Size Comparison by Region (M USD)
Table 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) by Company (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) AI Screening System as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Age-Related Macular Degeneration (AMD) AI Screening System Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (M USD)
Table 22. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) by Type (2020-2025)
Table 23. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Type (2020-2025)
Table 24. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
Table 25. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
Table 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2020-2025) & (M USD)
Table 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application (2020-2025)
Table 28. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 30. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2020-2025)
Table 31. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 34. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2020-2025) & (M USD)
Table 36. Airdoc Technology Basic Information
Table 37. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 38. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Airdoc Technology SWOT Analysis
Table 40. Airdoc Technology Business Overview
Table 41. Airdoc Technology Recent Developments
Table 42. Digital Diagnostics Basic Information
Table 43. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 44. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Digital Diagnostics SWOT Analysis
Table 46. Digital Diagnostics Business Overview
Table 47. Digital Diagnostics Recent Developments
Table 48. Eyenuk Basic Information
Table 49. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 50. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Eyenuk SWOT Analysis
Table 52. Eyenuk Business Overview
Table 53. Eyenuk Recent Developments
Table 54. RetinaLyze System Basic Information
Table 55. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 56. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 57. RetinaLyze System Business Overview
Table 58. RetinaLyze System Recent Developments
Table 59. Optomed Basic Information
Table 60. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 61. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Optomed Business Overview
Table 63. Optomed Recent Developments
Table 64. Sibionics Technology Basic Information
Table 65. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 66. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Sibionics Technology Business Overview
Table 68. Sibionics Technology Recent Developments
Table 69. Aeye Health Basic Information
Table 70. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 71. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Aeye Health Business Overview
Table 73. Aeye Health Recent Developments
Table 74. VUNO Basic Information
Table 75. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 76. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 77. VUNO Business Overview
Table 78. VUNO Recent Developments
Table 79. Medimaging Integrated Solution Basic Information
Table 80. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 81. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Medimaging Integrated Solution Business Overview
Table 83. Medimaging Integrated Solution Recent Developments
Table 84. EyRIS (SELENA+) Basic Information
Table 85. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 86. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 87. EyRIS (SELENA+) Business Overview
Table 88. EyRIS (SELENA+) Recent Developments
Table 89. Vistel Basic Information
Table 90. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 91. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Vistel Business Overview
Table 93. Vistel Recent Developments
Table 94. RETINA-AI Health Basic Information
Table 95. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 96. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 97. RETINA-AI Health Business Overview
Table 98. RETINA-AI Health Recent Developments
Table 99. Acer Medical Basic Information
Table 100. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Overview
Table 101. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Acer Medical Business Overview
Table 103. Acer Medical Recent Developments
Table 104. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2026-2035) & (M USD)
Table 105. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2026-2035) & (M USD)
Table 111. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Age-Related Macular Degeneration (AMD) AI Screening System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD), 2025-2035
Figure 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Product Life Cycle
Figure 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Company in 2025
Figure 13. Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) AI Screening System Revenue in 2025
Figure 15. Value Chain Map of Age-Related Macular Degeneration (AMD) AI Screening System
Figure 16. Global Age-Related Macular Degeneration (AMD) AI Screening System Market PEST Analysis
Figure 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Type
Figure 20. Market Share of Age-Related Macular Degeneration (AMD) AI Screening System by Type (2020-2025)
Figure 21. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application
Figure 24. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application (2020-2025)
Figure 25. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application in 2024
Figure 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2020-2025)
Figure 28. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2024
Figure 30. U.S. Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country in 2024
Figure 35. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2024
Figure 42. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 48. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2024
Figure 49. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Type (2026-2035)
Figure 61. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Age-Related Macular Degeneration (AMD) AI Screening System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD), 2025-2035
Figure 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Product Life Cycle
Figure 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Company in 2025
Figure 13. Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) AI Screening System Revenue in 2025
Figure 15. Value Chain Map of Age-Related Macular Degeneration (AMD) AI Screening System
Figure 16. Global Age-Related Macular Degeneration (AMD) AI Screening System Market PEST Analysis
Figure 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Type
Figure 20. Market Share of Age-Related Macular Degeneration (AMD) AI Screening System by Type (2020-2025)
Figure 21. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application
Figure 24. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application (2020-2025)
Figure 25. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Application in 2024
Figure 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2020-2025)
Figure 28. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2024
Figure 30. U.S. Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Country in 2024
Figure 35. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2024
Figure 42. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 48. South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2024
Figure 49. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Type (2026-2035)
Figure 61. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Application (2026-2035)
